Seborrheic Keratosis (SK) is the most common non-cancerous skin tumor, characterized by waxy, "stuck-on" lesions that typically appear in the middle-aged and elderly populations. While these growths are medically harmless, they frequently lead to significant patient discomfort, itching, and irritation, particularly when they rub against clothing or jewelry. As the global population continues to age, the incidence of SK is rising, creating a steady and growing demand for dermatological interventions that prioritize both therapeutic relief and patient safety.

The Seborrheic Keratosis Market is currently valued in the multi-billion dollar range, driven by a high prevalence rate and an increasing number of dermatological consultations. The market is primarily procedure-based, as clinical guidelines emphasize the physical removal of bothersome lesions. North America remains a dominant region due to advanced healthcare infrastructure and high patient awareness, while the Asia-Pacific region is emerging as a high-growth area. This regional expansion is supported by rising disposable incomes and an increasing number of specialized dermatology clinics offering localized treatment options.